Rapid, point-of-care nucleic acid test for HCV
Ended Project Grant Awarded Last action
- Award ID
- R44DK123849
- Recipient
-
Crosslife Technologies Inc. UEI LFE6DJ6KL4E5
- Awarding agency
-
National Institute of Diabetes and Digestive and Kidney Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,990,281
Award facts
- Assistance listing
- 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research
- Completion date
- Originally
- Place of performance
- Carlsbad, CA 92008, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $990,440 | |
| Original award | $999,841 |
Quick answers
Who received award R44DK123849?
R44DK123849 was awarded to Crosslife Technologies Inc. by National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health) on September 15, 2019.
How much is award R44DK123849 worth?
$1,990,281 has been obligated on R44DK123849.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award